Sign in

CIK 0001699382

  • Non-accelerated filer
  • Smaller reporting company

PMV Pharmaceuticals, Inc.

Sign in to watch
Ticker
PMVP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
463218129
Phone
+1 609-642-6670
Business address
400 ALEXANDER PARK DRIVE, SUITE 301, PRINCETON, NJ, 08540
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-05-12 LEVINE ARNOLD J Director Grant or award · Stock Option (right to buy) +5,781 5,781
2021-05-12 Jalota Deepika SVP, Regulatory Affairs and QA Grant or award · Employee Stock Option (right to buy) +22,674 22,674
2021-05-12 Alland Leila Chief Medical Officer Grant or award · Employee Stock Option (right to buy) +36,279 36,279
2021-05-12 Kung Winston COO, CFO Grant or award · Employee Stock Option (right to buy) +50,337 50,337
2021-05-12 Mack David Henry President and CEO Grant or award · Employee Stock Option (right to buy) +134,584 134,584
2021-05-10 Schroeder Thilo Director Sale −1,787 $35.67 $64K 2,104,414
2021-05-10 INTERWEST PARTNERS X LP 10% owner Other disposition −500,000 4,969,911
2021-05-10 INTERWEST PARTNERS X LP 10% owner Other acquisition +5,000 5,000
2021-05-10 INTERWEST PARTNERS X LP 10% owner Other disposition −5,000 0
2021-05-10 INTERWEST PARTNERS X LP 10% owner Other acquisition +186 559
2021-05-10 INTERWEST PARTNERS X LP 10% owner Other acquisition +125 375
2021-05-10 INTERWEST PARTNERS X LP 10% owner Other acquisition +1,135 3,404
2021-05-07 Alland Leila Chief Medical Officer Exercise or conversion +4,000 $3.90 $16K 4,000
2021-05-07 Alland Leila Chief Medical Officer Sale −3,842 $34.80 $134K 158
2021-05-07 Alland Leila Chief Medical Officer Sale −158 $35.49 $6K 0
2021-05-07 Alland Leila Chief Medical Officer Exercise or conversion · Employee Stock Option (right to buy) −4,000 369,850
2021-05-05 Schroeder Thilo Director Sale −600 $35.64 $21K 2,106,201
2021-05-03 Kung Winston COO, CFO Exercise or conversion +4,500 $3.22 $14K 6,100
2021-05-03 Kung Winston COO, CFO Sale −4,500 $33.75 $152K 1,600
2021-05-03 Kung Winston COO, CFO Exercise or conversion · Stock Option (right to buy) −4,500 232,534

Page 16 of 23 · 457 trades